Ground Swell Capital LLC Makes New $1.60 Million Investment in VanEck Pharmaceutical ETF $PPH

Ground Swell Capital LLC acquired a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 15,445 shares of the company’s stock, valued at approximately $1,604,000. VanEck Pharmaceutical ETF accounts for 3.2% of Ground Swell Capital LLC’s portfolio, making the stock its 3rd largest holding. Ground Swell Capital LLC owned approximately 0.16% of VanEck Pharmaceutical ETF at the end of the most recent quarter.

Several other large investors have also made changes to their positions in PPH. Banque Cantonale Vaudoise increased its stake in shares of VanEck Pharmaceutical ETF by 6.4% in the first quarter. Banque Cantonale Vaudoise now owns 1,907 shares of the company’s stock worth $198,000 after acquiring an additional 115 shares during the period. Axxcess Wealth Management LLC lifted its position in VanEck Pharmaceutical ETF by 9.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 9,885 shares of the company’s stock valued at $1,020,000 after purchasing an additional 841 shares during the period. Birchwood Financial Partners Inc. acquired a new position in VanEck Pharmaceutical ETF during the fourth quarter valued at $45,000. Wellington Management Group LLP purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at $42,134,000. Finally, Quadrature Capital Ltd purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter valued at $5,040,000.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH opened at $109.44 on Friday. The business’s 50-day moving average is $103.24 and its two-hundred day moving average is $104.61. The company has a market capitalization of $1.04 billion, a P/E ratio of 20.21 and a beta of 0.47. VanEck Pharmaceutical ETF has a fifty-two week low of $81.74 and a fifty-two week high of $112.58.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 7th. Stockholders of record on Wednesday, April 1st were paid a $0.8441 dividend. The ex-dividend date was Wednesday, April 1st. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $3.38 dividend on an annualized basis and a dividend yield of 3.1%.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.